Prevention and management of urinary tract infection: a non-antibiotic multi-modal approach

Arif A. Faruqui

doi:10.18203/2320-1770.ijrcog20243225

Authors

Arif A. Faruqui Department of Pharmacology, Clinical Pharmacologist, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20243225

Keywords:

Antibiotic, Recurrence, Non-antibiotic, Cranberry, D-mannose, Probiotics

Abstract

Urinary tract infections (UTIs) are widespread, with 7 million outpatient visits, 1 million emergency department visits, and 100,000 hospitalizations annually. They mainly affect women aged 20-50. Although antibiotics are the main treatment, around 30% of treated women experience recurrence (rUTI). Regular antibiotic use also raises the risk of antibiotic resistance and side effects. Additionally, antibiotics can disrupt the intestinal and vaginal flora, increasing the risk of recurrence. Therefore, non-antibiotic treatments should be considered to reduce antibiotic use and side effects. Non-antibiotic options such as cranberry juice, D-mannose, probiotics, and potassium magnesium citrate can alleviate UTI symptoms and reduce recurrence risk. Research suggests that combining these non-antibiotic treatments, which work through different mechanisms, leads to better clinical outcomes. This review examines the role of each non-antibiotic treatment, the rationale for their combination, and supports their effectiveness with clinical evidence. Thus, the combination of non-antibiotic treatments may offer a better outcome in patients with UTI and rUTI.

Metrics

Metrics Loading ...

References

Mohapatra S, Panigrahy R, Tak V, Shwetha JV, Sneha KC, Chaudhuri S, et al. Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiol. 2022;4(2):000321.

Pujades-Rodriguez M, West RM, Wilcox MH, Sandoe J. Lower Urinary Tract Infections: Management, Outcomes and Risk Factors for Antibiotic Re-prescription in Primary Care. E Clin Med. 2019;14:23-31.

Resistance Pattern in UTI: Indian and International Perspectives. Walter Bushnell Healthcare Foundation. Available at: https://wbhf.walterbushnell.com/ publications/bush-beats/item/67-resistance-pattern-in-uti-indian-and-international-perspectives#. Accessed on 17 August 2024.

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84.

Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev. 2012;36(3):616-48.

Abou Heidar NF, Degheili JA, Yacoubian AA, Khauli RB. Management of urinary tract infection in women: A practical approach for everyday practice. Urol Ann. 2019;11(4):339-46.

Jancel T, Dudas V. Management of uncomplicated urinary tract infections. West J Med. 2002;176(1):51-5.

Aggarwal N, Leslie SW, Lotfollahzadeh S. Recurrent Urinary Tract Infections. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2024.

Amawi HA, U'wais HT, Nusair MB, Al-okour R, Amawi S, Al-Shatnawi S, et al. Management of urinary tract infections and antibiotic susceptibility patterns of bacterial isolates. Int J Clin Pract. 2021;75(10):e14475.

Begum J. Antibiotics for UTI Treatment. WebMD. Available at: https://www.webmd.com/a-to-z-guides/ what-are-antibiotics-for-uti. Accessed on 12 May 2024.

Sabih A, Leslie SW. Complicated Urinary Tract Infections. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2024.

Kenneally C, Murphy CP, Sleator RD, Culligan EP. The urinary microbiome and biological therapeutics: Novel therapies for urinary tract infections. Microbiol Res. 2022;259:127010.

Gupta V, Nag D, Garg P. Recurrent urinary tract infections in women: How promising is the use of probiotics? Indian J Med Microbiol. 2017;35(3):347-54.

Sihra N, Goodman A, Zakri R, Sahai A, Malde S. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol. 2018;15(12):750-76.

Raz R, Chazan B, Dan M. Cranberry Juice and Urinary Tract Infection. Clin Infect Dis. 2004;143(12):891-4.

Lynch DM. Cranberry for prevention of urinary tract infections. Am Fam Physician. 2004;70(11):2175-7.

Ofek I, Beachey EH. Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun. 1978;22(1):247-54.

Hisano M, Bruschini H, Nicodemo AC, Srougi M. Cranberries and lower urinary tract infection prevention. Clinics (Sao Paulo). 2012;67(6):661-8.

Hidalgo G, Chan M, Tufenkji N. Inhibition of Escherichia coli CFT073 fliC expression and motility by cranberry materials. Appl Environ Microbiol. 2011;77(19):6852-7.

O'May C, Tufenkji N. The swarming motility of Pseudomonas aeruginosa is blocked by cranberry proanthocyanidins and other tannin-containing materials. Appl Environ Microbiol. 2011;77(9):3061-7.

Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005;66(18):2281-91.

Liu Y, Black MA, Caron L, Camesano TA. Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli. Biotechnol Bioeng. 2006;93(2):297-305.

Ren D, Zuo R, González Barrios AF, Bedzyk LA, Eldridge GR, Pasmore ME, et al. Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract ursolic acid. Appl Environ Microbiol. 2005;71(7):4022-34.

Davis JA, Freeze HH. Studies of mannose metabolism and effects of long-term mannose ingestion in the mouse. Biochim Biophys Acta. 2001;1528(2-3):116-26.

Fettweis JM, Brooks JP, Serrano MG, Sheth NU, Girerd PH, Edwards DJ, et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology (Reading). 2014;160(Pt 10):2272-82.

Fronzes R, Remaut H, Waksman G. Architectures and biogenesis of non-flagellar protein appendages in Gram-negative bacteria. EMBO J. 2008;27(17):2271-80.

Mydock-McGrane LK, Cusumano ZT, Janetka JW. Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease. Expert Opin Ther Pat. 2016;26(2):175-97.

Michaels EK, Chmiel JS, Plotkin BJ, Schaeffer AJ. Effect of D-mannose and D-glucose on Escherichia coli bacteriuria in rats. Urol Res. 1983;11(2):97-102.

Schaeffer AJ, Chmiel JS, Duncan JL, Falkowski WS. Mannose-sensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J Urol. 1984;131(5):906-10.

Velraeds MM, van der Mei HC, Reid G, Busscher HJ. Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl Environ Microbiol. 1996;62(6):1958-63.

Andreu A, Stapleton AE, Fennell CL, Hillier SL, Stamm WE. Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species. J Infect Dis. 1995;171(5):1237-43.

Osset J, Bartolomé RM, García E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis. 2001;183(3):485-91.

Mastromarino P, Brigidi P, Macchia S, Maggi L, Pirovano F, Trinchieri V, et al. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol. 2002;93(5):884-93.

Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin Ther. 2008;30(3):453-68.

Zárate G, Nader-Macias ME. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol. 2006;43(2):174-80.

Manzoor A, Ul-Haq I, Baig S, Qazi JI, Seratlic S. Efficacy of Locally Isolated Lactic Acid Bacteria Against Antibiotic-Resistant Uropathogens. Jundishapur J Microbiol. 2016;9(1):e18952.

Shim YH, Lee SJ, Lee JW. Antimicrobial activity of lactobacillus strains against uropathogens. Pediatr Int. 2016;58(10):1009-13.

Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704-12.

Mehta P, Leslie SW, Reddivari AKR. Dysuria. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2024.

Wrenn K. Dysuria, Frequency, and Urgency. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths. 1990.

O'Kane DB, Dave SK, Gore N, Patel F, Hoffmann TC, Trill JL, et al. Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women. Cochrane Database Syst Rev. 2016;4(4):CD010745.

EMC. Potassium citrate (mixture). Medicines UK. Available at: https://www.medicines.org.uk/emc/ landing?status=1#gref. Accessed on 12 May 2024.

Gupta K, Chou MY, Howell A, Wobbe C, Grady R, Stapleton AE. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol. 2007;177(6):2357-60.

Howell AB, Vorsa N, Der Marderosian A, Foo LY. Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med. 1998;339(15):1085-6.

Rădulescu D, David C, Turcu FL, Spătaru DM, Popescu P, Văcăroiu IA. Combination of cranberry extract and D-mannose - possible enhancer of uropathogen sensitivity to antibiotics in acute therapy of urinary tract infections: Results of a pilot study. Exp Ther Med. 2020;20(4):3399-406.

Vicariotto F. Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: a pilot study. J Clin Gastroenterol. 2014;48(1):S96-101.

Pugliese D, Acampora A, Porreca A, Schips L, Cindolo L. Effectiveness of a novel oral combination of D-Mannose, pomegranate extract, prebiotics and probiotics in the treatment of acute cystitis in women. Arch Ital Urol Androl. 2020;92(1):34-8.